Literature DB >> 2451920

Two Ro (SS-A) autoantibody responses in systemic lupus erythematosus. Correlation of HLA-DR/DQ specificities with quantitative expression of Ro (SS-A) autoantibody.

R G Hamilton1, J B Harley, W B Bias, M Roebber, M Reichlin, M C Hochberg, F C Arnett.   

Abstract

Autoantibodies to Ro (SS-A), La (SS-B), and Sm/nuclear RNP were quantitated by enzyme-linked immunosorbent assay in 106 white patients with systemic lupus erythematosus. Two Ro autoantibody subgroups were identified that differed quantitatively, genetically, and clinically. The subgroup having anti-Ro only demonstrated significantly lower mean anti-Ro levels than did the subgroup with concomitant anti-La and showed a strong association with the linked HLA alleles DR2 and DQw1. The anti-Ro with anti-La subgroup was associated with the linked HLA alleles B8, DR3, DRw52, and DQw2 (DR3 was primary), and this subgroup consisted of patients with older ages at disease onset, sicca complex, and less renal involvement. Overall, the relative risk (RR) for having anti-Ro was highest in HLA-DR2/DR3 heterozygotes compared with non-DR2/DR3 heterozygotes (RR 15) and all other DR combinations (RR 7), suggesting a compound effect of 2 immune responses. Heterozygotes for HLA-DQw1/DQw2 demonstrated significantly higher mean levels of anti-Ro, which may be indicative of trans gene interaction at HLA-DQ. These data suggest the hypothesis that HLA genes exert their major effects on Ro/La autoantibody subsets of systemic lupus erythematosus.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2451920     DOI: 10.1002/art.1780310406

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  41 in total

Review 1.  Antinuclear antibodies to RNA-binding proteins in SLE.

Authors:  P J Maddison
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

2.  HLA class II restriction of autoantibody production in patients with systemic lupus erythematosus.

Authors:  H A Stephens; N J McHugh; P J Maddison; D A Isenberg; K I Welsh; G S Panayi
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

3.  The genetic basis of Ro and La antibody formation in systemic lupus erythematosus. Results of a multicenter study. The SLE Study Group.

Authors:  K Hartung; H Ehrfeld; H J Lakomek; R Coldewey; B Lang; F Krapf; R Müller; D Schendel; H Deicher; H P Seelig
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

Review 4.  Autoantibodies to the RoRNP particles.

Authors:  M Reichlin
Journal:  Clin Exp Immunol       Date:  1995-01       Impact factor: 4.330

5.  HLA-DQw7 is a disease severity marker in patients with rheumatoid arthritis.

Authors:  H A Stephens; L I Sakkas; R W Vaughan; I Teitsson; K I Welsh; G S Panayi
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

Review 6.  Reactivation of Epstein-Barr virus in Sjögren's syndrome.

Authors:  R I Fox; M Luppi; H I Kang; P Pisa
Journal:  Springer Semin Immunopathol       Date:  1991

7.  Antiphospholipid antibodies and HLA associations in primary Sjögren's syndrome.

Authors:  R A Asherson; H M Fei; H L Staub; M A Khamashta; G R Hughes; R I Fox
Journal:  Ann Rheum Dis       Date:  1992-04       Impact factor: 19.103

8.  MHC class II, tumour necrosis factor alpha, and lymphotoxin alpha gene haplotype associations with serological subsets of systemic lupus erythematosus.

Authors:  N J McHugh; P Owen; B Cox; J Dunphy; K Welsh
Journal:  Ann Rheum Dis       Date:  2005-08-17       Impact factor: 19.103

9.  Seizures in patients with systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA LIV).

Authors:  R M Andrade; G S Alarcón; L A González; M Fernández; M Apte; L M Vilá; G McGwin; J D Reveille
Journal:  Ann Rheum Dis       Date:  2007-09-17       Impact factor: 19.103

10.  Antibodies against Ku protein in sera from patients with autoimmune diseases.

Authors:  M Yaneva; F C Arnett
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.